| The biotechnology firm announced Monday that in addition to the high rate of disease prevention overall, the shot reduced severe cases of illness — a striking initial result. The finding comes a week after Pfizer and its German partner, BioNTech, reported their coronavirus vaccine was more than 90 percent effective and means the United States could have two vaccines available on a limited basis by the end of this year. | 
No comments:
Post a Comment